Strata Critical Medical (SRTA) Stock Analysis & Winston Score
Strata Critical Medical, Inc. (ticker: SRTA) does not appear to match the industry and sector data provided — a medical company classified under Airlines, Airports & Air Services is an unusual combination, and reliable public information on this specific company is limited. Based on the available data, this appears to be a small-cap company with roughly $500 million in market value operating in the industrials space, though the exact nature of its products and customers is unclear. What the financials do reveal is that the company earns a modest gross margin of around 20%, while losing money at the operating level, with a negative operating margin of 6% and a negative return on invested capital. This suggests the business is still in a growth or turnaround phase and has not yet reached profitability. The main risk facing the company is its current inability to cover operating costs, which could pressure cash reserves and require additional financing if losses continue.
Winston Score: 21/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (2/30)
- Growth: Weak (3/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
